尿液肾损伤生物标志物与心血管疾病事件及全因死亡风险:CRIC研究
在CRIC研究2466例CKD参与者中,检测尿KIM-1、NGAL、L-FABP和NAG并随访中位6.5年,发现部分尿肾损伤标志物与心衰、动脉粥样硬化性CVD事件及全因死亡风险独立相关,其中仅KIM-1/Cr与全部三种结局相关。
要点
- 尿KIM-1/Cr最高五分位者心衰风险较最低五分位升高(aHR 1.73)。
- 仅KIM-1/Cr与动脉粥样硬化性CVD事件独立相关(aHR 1.21)。
- KIM-1/Cr和NGAL/Cr最高五分位均与全因死亡风险升高相关。
核心结论
- 在CRIC研究中,部分尿肾损伤生物标志物与心衰、CVD事件和死亡风险升高独立相关,所检标志物中仅KIM-1/Cr与每一种结局均相关。
- 作者认为需要进一步研究以确定这些标志物能否改善上述不良结局的风险预测。
研究设计与样本
- CRIC研究子集分析,纳入2466例参与者,检测尿KIM-1、NGAL、L-FABP和NAG并以尿肌酐校正。
- 采用Cox比例风险回归分析标志物与心衰、动脉粥样硬化性CVD事件复合终点及全因死亡的关联。
主要发现
- 基线平均年龄59.5±10.8岁,46%为女性,34%自报有任一CVD病史。
- 中位随访6.5(四分位距5.6-6.8)年,观察到333例心衰事件、282例动脉粥样硬化性CVD事件和440例死亡。
- KIM-1/Cr最高五分位 vs 最低五分位的心衰aHR为1.73(95%CI 1.05-2.85)。
- NAG/Cr连续分析中心衰aHR为每log SD升高1.18(95%CI 1.01-1.38)。
- 仅KIM-1/Cr与动脉粥样硬化性CVD事件独立相关(每log SD升高aHR 1.21,95%CI 1.02-1.41)。
临床怎么用
- 原文未据此给出推荐。
- 作者认为需要进一步研究以确定这些标志物改善风险预测的效用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: CKD is an important risk factor for cardiovascular disease (CVD) and death. We investigated whether select urine kidney injury biomarkers were associated with higher risk of heart failure (HF), CVD, and death in persons with CKD enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Urine kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin, liver fatty acid-binding protein, and N-acetyl-β-d-glucosaminidase were measured in urine of a subset of CRIC participants (n=2466). We used Cox proportional hazards regression to examine associations between these biomarkers indexed to urinary creatinine (Cr) and (1) HF, (2) a composite of atherosclerotic CVD events (myocardial infarction, ischemic stroke, or peripheral artery disease), and (3) all-cause death. RESULTS: At baseline, mean age of study participants was 59.5±10.8 years, 46% were women, and 34% had a self-reported history of any CVD. Median follow-up was 6.5 (interquartile range, 5.6-6.8) years. A total of 333 HF events, 282 atherosclerotic CVD events, and 440 deaths were observed during a median follow-up of 6.5 (interquartile range, 5.6-6.8) years. Those in the highest two quintiles of KIM-1/Cr levels had a higher risk of HF relative to the lowest quintile (quintile 5 versus quintile 1 adjusted hazard ratio [aHR] of 1.73 [95% confidence interval, 1.05 to 2.85]). N-acetyl-β-d-glucosaminidase/Cr was associated with HF in continuous analyses (aHR per log SD higher 1.18 [95% confidence interval, 1.01 to 1.38]). Only KIM-1/Cr was independently associated with atherosclerotic CVD events (aHR per log SD higher 1.21 [95% confidence interval, 1.02 to 1.41]), whereas both KIM-1/Cr (quintile 5 versus quintile 1 aHR of 1.56 [95% confidence interval, 1.06 to 2.31]) and neutrophil gelatinase-associated lipocalin/Cr (quintile 5 versus quintile 1 aHR of 1.82 [95% confidence interval, 1.19 to 2.8]) were associated with all-cause death. CONCLUSIONS: Selected urine kidney injury biomarkers were independently associated with higher risk of HF, CVD events, and death in CRIC. Among the biomarkers examined, only KIM-1/Cr was associated with each outcome. Further work is needed to determine the utility of these biomarkers to improve risk prediction for these adverse outcomes.
引用
- Park M, Hsu CY, Go AS, et al. Urine Kidney Injury Biomarkers and Risks of Cardiovascular Disease Events and All-Cause Death: The CRIC Study. Clin J Am Soc Nephrol. 2017. PMID: 28254771. doi:10.2215/CJN.08560816
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。